Factors of loss to follow-up during tuberculosis treatment in a low-incidence region

Tetart, M.; Meybeck, Agnes; Assaf, A.; Valette, Michel; Choisy, P.; Blondiaux, Nicolas; Senneville, Eric

Document type :

Article dans une revue scientifique: Article original

DOI :

10.1016/j.medmal.2019.02.007

PMID :

30890281

Permalink :

http://hdl.handle.net/20.500.12210/16755

Title :

Factors of loss to follow-up during tuberculosis treatment in a low-incidence region

Author(s) :

Tetart, M. [Auteur]
Meybeck, Agnes [Auteur]
Assaf, A. [Auteur]
Valette, Michel [Auteur]
Choisy, P. [Auteur]
Blondiaux, Nicolas [Auteur]
Senneville, Eric [Auteur]

Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694

Journal title :

Medecine et maladies infectieuses

Abbreviated title :

Med Mal Infect

Publication date :

2019-03-16

ISSN :

1769-6690

HAL domain(s) :

Sciences du Vivant [q-bio]

English abstract : [en]

OBJECTIVE: The proportion of successfully treated tuberculosis (TB) patients remains below the WHO target in France, because of a high proportion of loss to follow-up. We aimed to identify factors associated with loss to ...
Show more >OBJECTIVE: The proportion of successfully treated tuberculosis (TB) patients remains below the WHO target in France, because of a high proportion of loss to follow-up. We aimed to identify factors associated with loss to follow-up in northern France, a low-incidence area. METHODS: Between 1997 and 2017, all consecutive patients diagnosed with TB at the Tourcoing Hospital, except those infected with multidrug-resistant or extensively drug-resistant strains, were included in a retrospective cohort study. A logistic regression analysis was performed to determine factors associated with loss to follow-up. RESULTS: One hundred and ninety patients were included. Previous TB treatment was reported in 32 patients (17%), extrapulmonary TB in 107 (56%), and HIV infection in 44 (23%). The proportion of loss to follow-up was 15%. In multivariate analysis, the risk of loss to follow-up decreased in case of first TB treatment (OR 0.36; 95% CI: 0.14-0.92, P=0.03) and increased in non-HIV-infected patients (OR 7.67; 95% CI: 1.00-59.0, p=0.05). Support for compliance was more frequent in HIV-infected patients (23% vs. 7%, p=0.005). CONCLUSIONS: The proportion of loss to follow-up was high. HIV infection was associated with a lower risk of loss to follow-up, likely to be due to more frequent support for compliance.Show less >

Language :

Anglais

Audience :

Internationale

Popular science :

Non

Administrative institution(s) :

CHU Lille
Université de Lille

Collections :

METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694

Submission date :

2019-12-09T16:48:17Z

Version	Link	Modification date
2	20.500.12210/16755	2024-03-27T10:39:32Z
1	20.500.12210/16755.1*	2019-12-09T16:48:17Z

Factors of loss to follow-up during ...

BibTeX

CSV

Excel

RIS

Notice

Version history

Factors of loss to follow-up during ... BibTeX CSV Excel RIS

Notice

Version history

Factors of loss to follow-up during ...

BibTeX

CSV

Excel

RIS